Copyright Licensing Agency Licence Certificate 2023-24

This is to certify that The Copyright Licensing Agency Limited (“CLA”) has granted a Licence...

View document

MHRA Phase I Accreditation Certificate (October 2023)

The accreditation is based on the Unit continuing to maintain satisfactory standards for avoiding harm to trial subjects and for handling medical emergencies should they arise.

View document

MHRA Phase I Accreditation Certificate (01 June 2022)

The accreditation is based on the Unit continuing to maintain satisfactory standards for avoiding harm to trial subjects and for handling medical emergencies should they arise.

View document

MHRA Phase I Accreditation Certificate (August 2020)

MHRA Phase I Accreditation Certificate (August 2020)

View document

MHRA Phase I Accreditation Certificate (April 2017)

MHRA Phase I Accreditation Certificate (April 2017)

View document

MHRA Phase I Accreditation Certificate (March 2015)

MHRA Phase I Accreditation Certificate (March 2015)

View document

MHRA Phase I Accreditation Certificate (March 2013)

MHRA Phase I Accreditation Certificate (March 2013)

View document

Corporate Accounts 2021

Corporate Accounts 2021

View document

Corporate Accounts 2020

Corporate Accounts 2020

View document

Corporate Accounts 2019

Corporate Accounts 2019

View document

Corporate Accounts 2018

Corporate Accounts 2018

View document

Latest news

Richmond Appoints Lisa Campbell as Director of Regulatory Strategy

April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read more

Von Willebrand Disease Trial – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol

April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read more

Events

Swiss Biotech Day 2025

5–6 May 2025
Richmond Pharmacology is pleased to confirm our participation at Swiss Biotech Day 2025
View event